Humana (HUM)

ECGI Holdings (OTC: ECGI) is featured in an AINewsWire editorial examining the shift toward preventive, coordinated healthcare and the growing role of artificial intelligence in improving patient outcomes and managing costs. The editorial highlights ECGI’s acquisition of Avanta Group, a developing integrated healthcare platform encompassing Medicare Advantage insurance, management services, AI-enabled technology, consumer health and healthcare infrastructure. The acquisition positions ECGI to pursue opportunities in a U.S. healthcare market that reached $5.3 trillion in 2024, with Medicare Advantage payments projected to total $574 billion in 2026. The editorial also discusses the potential for integrated technology and care coordination to improve efficiency, patient engagement and access to services.

AUSTIN, Texas, Oct. 19, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: American healthcare is moving from treating illness after it strikes to preventing it before it starts. U.S. health spending reached $5.3 trillion in 2024, and Medicare Advantage now covers 35.2 million people, or 55% of eligible beneficiaries. KFF projects Medicare Advantage payments of $574 billion in 2026, giving health plans a powerful reason to keep members healthy. That shift is opening the door for a new kind of player. ECGI Holdings Inc. (OTC: ECGI) (profile) has completed its acquisition of Avanta Group, a developing platform that spans a Medicare Advantage health plan, management services and AI-enabled health technology. The acquisition gives ECGI a direct path into coordinated, proactive care just as the industry is searching for better ways to deliver it. ECGI is working alongside others operating in the U.S. managed healthcare ecosystem, including industry leaders such as United Health Group Inc. (NYSE: UNH), CVS Health Corporation (NYSE: CVS), Elevance Health Inc. (NYSE: ELV) and Humana Inc. (NYSE: HUM).

InvidiaTrade ve la inteligencia artificial como una herramienta para ayudar a los traders a analizar su comportamiento, identificar errores recurrentes y construir procesos de toma de decisiones más estructurados.

DataMeds AI, Inc. (NASDAQ:MEDS) today announced that it has implemented cost control measures, primarily through reductions in corporate management positions, to focus the workforce spend on commercializing ChemoFx® as a diagnostic lab test to help oncologists inform their chemotherapy regimen selection, initially for gynecologic cancers only.

Humana Inc. (NYSE: HUM) today announced it has entered into a new joint venture agreement with funds and accounts managed by HPS Investment Partners, a part of BlackRock (“BlackRock”), to manage and operate an existing network of nearly 150 CenterWell Senior Primary Care clinics that currently sit within joint ventures owned by funds affiliated with WCAS and CenterWell. The new joint venture, majority owned by BlackRock and minority owned by CenterWell, will replace the current CenterWell and WCAS joint ventures that were instrumental in successfully scaling CenterWell into the nation’s largest provider of senior-focused value-based primary care over the last seven years.

Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2026 (3Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on November 6, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.

DataMeds AI, Inc. (NASDAQ:MEDS) today announced that its recently acquired CLIA-certified precision oncology laboratory subsidiary Helomics Corporation has received a Medicaid coverage determination in gynecologic cancers for the ChemoFx® Assay.

On Oct. 9, 2026, major benchmarks recover from earlier volatility as AI jitters and geopolitical tensions ease.

What Happened? Shares of health insurance company Humana (NYSE:HUM) jumped 16.8% in the pre-market session after Robert W. Baird upgraded the company to Outp...

Humana Inc. (NYSE: HUM), a leading consumer healthcare company focused on helping people achieve their best health, today announced improved Star Ratings for 2027, highlighted by 95% of its Medicare Advantage members being enrolled in plans rated 4.0 stars or above by the Centers for Medicare and Medicaid Services (CMS). Additionally, 42% of Humana Medicare Advantage members are enrolled in 4.5-star plans for 2027.

A four-star rating makes a big plan eligible for bonus payments in 2027.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Humana Inc. (NYSE: HUM) and the University of Louisville today announced the publication of a new economic impact report examining Humana’s contributions across the state. The analysis, authored by University of Louisville applied economist Thomas E. Lambert, PhD, found that Humana’s operations generated nearly $20 billion in economic activity across Kentucky in 2025, supporting jobs, businesses and communities throughout the Commonwealth.

MIAMI, FL, October 5, 2026 -- New psychiatric practice next to Jackson South Medical Center offers evaluations and medication management in English and Spanish, in person and by telehealth across Florida

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit...